NEW YORK (GenomeWeb) – Scipio Bioscience said today that it has completed a seed financing round of €1.2 million ($1.4 million) to fund development and commercialization of its first prototype kit for single-cell transcriptomics.

Paris-based Seventure Partners' Quadrivium I seed fund and Bonn, Germany-based High-Tech Gründerfonds participated in the funding.

Scipio uses a proprietary technology based on barcoding in a test tube format to prepare samples for single-cell profiling.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.